The Global Summit on Generic Drugs and Quality Control covers topics such as:
- Modernization of Bioequivalence Standards for Generic Products
- Best Practices & Strategies for Generic Drug Development
- Bioequivalence approaches for complex injectable API and formulations
- Application of Quantitative systems pharmacology (QSP)
- Pharmaceutical Quality Assurance
- Generic Animal Drug
- Acceptance of Generic Drugs by People
- Challenges of Manufacturing Generic Drugs
- Biosimilars
- Challenges of Marketing Generic Drugs
- Quality by Design (QbD) for generic drugs
- Current Good manufacturing practices (CGMP)
- Super Generic drugs and Bio Betters
- Global Generic Trends
- Complex Generic Drug Product
- Patent Access& Intellectual property& FDA Regulations
- Generic Drug Market
The Global Summit on Generic Drugs and Quality Control brings together:
- Research & Development
- Clinical Researchers
- Public Health Advisors
- Pharmacists
- Pharmacology
- Regulatory Affairs
- Quality Assurance/Control
- Safety/Pharmacovigilance
- CMC/ GMP
- Manufacturing companies
- Veterinarians
- Medical practitioners
- Students
